Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-003200
Filing Date
2019-01-28
Accepted
2019-01-28 17:25:02
Documents
6
Period of Report
2019-03-20
Effectiveness Date
2019-01-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv511653_def14a.htm DEF 14A 250928
2 GRAPHIC tv511653_img1.jpg GRAPHIC 8783
3 GRAPHIC tv511653_img2.jpg GRAPHIC 12481
4 GRAPHIC tv511653_img3.jpg GRAPHIC 5418
5 GRAPHIC tv511653_img4.jpg GRAPHIC 201570
6 GRAPHIC tv511653_img5.jpg GRAPHIC 130592
  Complete submission text file 0001144204-19-003200.txt   746869
Mailing Address 2701 KENT AVENUE WEST LAFAYETTE IN 47906-1382
Business Address 2701 KENT AVE WEST LAFAYETT IN 47906-1382 3174634527
BIOANALYTICAL SYSTEMS INC (Filer) CIK: 0000720154 (see all company filings)

EIN.: 351345024 | State of Incorp.: IN | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-23357 | Film No.: 19546491
SIC: 8731 Services-Commercial Physical & Biological Research